← Back to ANIX

Anixa Biosciences, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJul 2026Filed 09/09/2026Apr 2026Filed 10/06/2026Jan 2026Filed 09/03/2026Jul 2025Filed 09/09/2026Apr 2025Filed 10/06/2026Jan 2025Filed 09/03/2026Jul 2024Filed 10/09/2025Apr 2024Filed 28/05/2025
−$2.6−$2.5−$2.6−$2.3−$2.8−$3.2−$3.3−$3.1
−$0.08−$0.07−$0.08−$0.07−$0.09−$0.10−$0.10−$0.10
3434333232323232

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.